CellCentric Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2003-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cellcentric.com
Study to Evaluate CCS1477 in Haematological Malignancies
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- CellCentric Ltd.
- Target Recruit Count
- 250
- Registration Number
- NCT04068597
- Locations
- 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
🇬🇧The Royal Marsden, Sutton, Surrey, United Kingdom
🇫🇷Institute Gustave Roussy, Villejuif, France
Study to Evaluate CCS1477 in Advanced Tumours
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- CellCentric Ltd.
- Target Recruit Count
- 350
- Registration Number
- NCT03568656
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States
© Copyright 2024. All Rights Reserved by MedPath